Pharmacotherapy : a pathophysiologic approach /

Saved in:
Bibliographic Details
Uniform title:Pharmacotherapy (New York)
Edition:Tenth edition.
Imprint:New York : McGraw-Hill Education, [2017]
Description:xxxiii, 2474 pages ; 29 cm
Language:English
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11432318
Hidden Bibliographic Details
Other authors / contributors:DiPiro, Joseph T., editor.
ISBN:9781259587481
1259587487
Notes:Includes bibliographical references and index.
Table of Contents:
  • Section 1: Foundation Issues
  • Chapter e1: Health Literacy and Medication Use
  • Chapter e2: Cultural Competency
  • Chapter e3: Medication Safety Principles and Practices
  • Chapter e4: Clinical Pharmacokinetics and Pharmacodynamics
  • Chapter e5: Pharmacogenetics
  • Chapter e6: Pediatrics
  • Chapter e7: Geriatrics
  • Chapter e8: Palliative Care
  • Chapter e9: Clinical Toxicology
  • Chapter e10: Clinical Management of Potential Bioterrorism-related Conditions
  • Section 2: Cardiovascular Disorders
  • Chapter e11: Cardiovascular Testing
  • Chapter 12: Cardiac Arrest
  • Chapter 13: Hypertension
  • Chapter 14: Chronic Heart Failure
  • Chapter 15: Acute Decompensated Heart Failure
  • Chapter 16: Stable Ischemic Heart Disease
  • Chapter 17: Acute Coronary Syndromes
  • Chapter 18: The Arrhythmias
  • Chapter 19: Venous Thromboembolism
  • Chapter 20: Stroke
  • Chapter 21: Dyslipidemia
  • Chapter e22: Peripheral Arterial Disease
  • Chapter 23: Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock
  • Chapter 24: Hypovolemic Shock
  • Chapter e25: Introduction to Pulmonary Function Testing
  • Section 3: Respiratory Disorders
  • Chapter 26: Asthma
  • Chapter 27: Chronic Obstructive Pulmonary Disease
  • Chapter 28: Pulmonary Arterial Hypertension
  • Chapter 29: Cystic Fibrosis
  • Chapter e30: Drug-Induced Pulmonary Diseases
  • Section 4: Gastrointestinal Disorders
  • Chapter e31: Evaluation of the Gastrointestinal Tract
  • Chapter 32: Gastroesophageal Reflux Disease
  • Chapter 33: Peptic Ulcer Disease and Related Disorders
  • Chapter 34: Inflammatory Bowel Disease
  • Chapter 35: Nausea and Vomiting
  • Chapter 36: Diarrhea, Constipation, and Irritable Bowel Syndrome
  • Chapter 37: Portal Hypertension and Cirrhosis
  • Chapter e38: Drug-Induced Liver Disease
  • Chapter 39: Pancreatitis
  • Chapter 40: Viral Hepatitis
  • Chapter 41: Celiac Disease
  • Section 5: Renal Disorders
  • Chapter e42: Evaluation of Kidney Function
  • Chapter 43: Acute Kidney Injury
  • Chapter 44: Chronic Kidney Disease
  • Chapter 45: Hemodialysis and Peritoneal Dialysis
  • Chapter 46: Drug-Induced Kidney Disease
  • Chapter 47: Glomerulonephritis
  • Chapter 48: Drug Therapy Individualization for Patients with Chronic Kidney Disease
  • Chapter 49: Disorders of Sodium and Water Homeostasis
  • Chapter 50: Disorders of Calcium and Phosphorus Homeostasis
  • Chapter 51: Disorders of Potassium and Magnesium Homeostasis
  • Chapter 52: Acid-Base Disorders
  • Section 6: Neurologic Disorders
  • Chapter e53: Evaluation of Neurologic Illness
  • Chapter 54: Alzheimer Disease
  • Chapter 55: Multiple Sclerosis
  • Chapter 56: Epilepsy
  • Chapter 57: Status Epilepticus
  • Chapter 58: Acute Management of the Brain Injury Patient
  • Chapter 59: Parkinson Disease
  • Chapter 60: Pain Management
  • Chapter 61: Headache Disorders
  • Section 7: Psychiatric Disorders
  • Chapter e62: Assessment of Psychiatric Disorders
  • Chapter 63: Attention Deficit/Hyperactivity Disorder
  • Chapter 64: Eating Disorders
  • Chapter 65: Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens
  • Chapter 66: Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine
  • Chapter 67: Schizophrenia
  • Chapter 68: Major Depressive Disorder
  • Chapter 69: Bipolar Disorder
  • Chapter 70: Anxiety Disorders: Generalized Anxiety, Panic, and Social Anxiety Disorders.
  • Chapter 71: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder
  • Chapter 72: Sleep-Wake Disorders
  • Chapter 73: Disorders Associated with Intellectual Disabilities
  • Section 8: Endocrinologic Disorders
  • Chapter 74: Diabetes Mellitus
  • Chapter 75: Thyroid Disorders
  • Chapter 76: Adrenal Gland Disorders
  • Chapter e77: Pituitary Gland Disorders
  • Section 9: Gynecologic and Obstetric Disorders
  • Chapter 78: Pregnancy and Lactation: Therapeutic Considerations
  • Chapter 79: Contraception
  • Chapter 80: Menstruation-Related Disorders
  • Chapter 81: Endometriosis
  • Chapter 82: Hormone Therapy in Women
  • Section 10: Urologic Disorders
  • Chapter 83: Erectile Dysfunction
  • Chapter 84: Benign Prostatic Hyperplasia
  • Chapter 85: Urinary Incontinence
  • Section 11: Immunologic Disorders
  • Chapter e86: Function and Evaluation of the Immune System
  • Chapter 87: Systemic Lupus Erythematosus
  • Chapter e88: Drug Allergy
  • Chapter 89: Solid-Organ Transplantation
  • Section 12: Rheumatologic Disorders
  • Chapter 90: Osteoarthritis
  • Chapter 91: Rheumatoid Arthritis
  • Chapter 92: Osteoporosis and Osteomalacia
  • Chapter 93: Gout and Hyperuricemia
  • Section 13: Ophthalmic and Otolaryngological Disorders
  • Chapter 94: Glaucoma
  • Chapter 95: Allergic Rhinitis
  • Section 14: Dermatologic Disorders
  • Chapter 96: Acne Vulgaris
  • Chapter 97: Psoriasis
  • Chapter 98: Atopic Dermatitis
  • Chapter e99: Dermatologic Drug Reactions and Common Skin Conditions
  • Section 15: Hematologic Disorders
  • Chapter 100: Anemias
  • Chapter 101: Coagulation Disorders
  • Chapter 102: Sickle Cell Disease
  • Chapter e103: Drug-Induced Hematologic Disorders
  • Section 16: Infectious Diseases
  • Chapter e104: Laboratory Tests to Direct Antimicrobial Pharmacotherapy
  • Chapter 105: Antimicrobial Regimen Selection
  • Chapter 106: Central Nervous System Infections
  • Chapter 107: Lower Respiratory Tract Infections
  • Chapter 108: Upper Respiratory Tract Infections
  • Chapter 109: Influenza
  • Chapter 110: Skin and Soft-Tissue Infections
  • Chapter 111: Infective Endocarditis
  • Chapter 112: Tuberculosis
  • Chapter 113: Gastrointestinal Infections and Enterotoxigenic Poisonings
  • Chapter 114: Intra-Abdominal Infections
  • Chapter 116: Urinary Tract Infections and Prostatitis
  • Chapter e115: Parasitic Diseases
  • Chapter 117: Sexually Transmitted Diseases
  • Chapter 118: Bone and Joint Infections
  • Chapter 119: Sepsis and Septic Shock
  • Chapter 120: Superficial Fungal Infections
  • Chapter 121: Invasive Fungal Infections
  • Chapter 122: Infections in Immunocompromised Patients
  • Chapter 123: Antimicrobial Prophylaxis in Surgery
  • Chapter e124: Travel Health
  • Chapter 125: Vaccines and Immunoglobulins
  • Chapter 126: Human Immunodeficiency Virus Infection
  • Section 17: Oncologic Disorders
  • Chapter 127: Cancer Treatment and Chemotherapy
  • Chapter 128: Breast Cancer
  • Chapter 129: Lung Cancer
  • Chapter 130: Colorectal Cancer
  • Chapter 131: Prostate Cancer
  • Chapter 132: Lymphomas
  • Chapter 133: Ovarian Cancer
  • Chapter 134: Acute Leukemias
  • Chapter 135: Chronic Leukemias
  • Chapter 136: Multiple Myeloma
  • Chapter e137: Myelodysplastic Syndromes
  • Chapter e138: Renal Cell Carcinoma
  • Chapter 139: Melanoma
  • Chapter 140: Hematopoietic Stem Cell Transplantation
  • Section 18: Nutritional Disorders
  • Chapter 141: Assessment of Nutrition Status and Nutrition Requirements
  • Chapter 142: Parenteral Nutrition
  • Chapter 143: Enteral Nutrition
  • Chapter 144: Obesity.